These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33924461)

  • 21. Niacin Alleviates Dairy Cow Mastitis by Regulating the GPR109A/AMPK/NRF2 Signaling Pathway.
    Guo W; Liu J; Li W; Ma H; Gong Q; Kan X; Cao Y; Wang J; Fu S
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
    Donepudi AC; Boehme S; Li F; Chiang JY
    Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.
    Li G; Deng X; Wu C; Zhou Q; Chen L; Shi Y; Huang H; Zhou N
    J Biol Chem; 2011 Sep; 286(36):31199-212. PubMed ID: 21768093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.
    Feingold KR; Moser A; Shigenaga JK; Grunfeld C
    J Lipid Res; 2014 Dec; 55(12):2501-8. PubMed ID: 25320346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GPR109A activation and aging liver.
    Jadeja RN; Martin PM
    Aging (Albany NY); 2019 Oct; 11(19):8044-8045. PubMed ID: 31596730
    [No Abstract]   [Full Text] [Related]  

  • 27. Nicotinic Acid Receptor GPR109A Exerts Anti-Inflammatory Effects Through Inhibiting the Akt/mTOR Signaling Pathway in MIN6 Pancreatic β cells.
    Li Z; Li X; Lin S; Chen Y; Ma S; Fu Y; Wei C; Xu W
    Ann Clin Lab Sci; 2017 Nov; 47(6):729-737. PubMed ID: 29263047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Niacin/β-hydroxybutyrate regulates milk fat and milk protein synthesis
    Chen J; Lin T; Zhang S; Yue X; Liu X; Wu C; Liang Y; Zeng X; Ren M; Chen F; Guan W; Zhang S
    Food Funct; 2023 Mar; 14(6):2642-2656. PubMed ID: 36866679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.
    Lukasova M; Malaval C; Gille A; Kero J; Offermanns S
    J Clin Invest; 2011 Mar; 121(3):1163-73. PubMed ID: 21317532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niacin Ameliorates Neuro-Inflammation in Parkinson's Disease via GPR109A.
    Giri B; Belanger K; Seamon M; Bradley E; Purohit S; Chong R; Morgan JC; Baban B; Wakade C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of metabolite sensing receptor HCA2 impairs the salutary effect of niacin in hemorrhagic shock.
    Subramani K; Chu X; Warren M; Lee M; Lu S; Singh N; Raju R
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):688-695. PubMed ID: 30625381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis.
    Jadeja RN; Jones MA; Fromal O; Powell FL; Khurana S; Singh N; Martin PM
    Aging (Albany NY); 2019 Jan; 11(2):386-400. PubMed ID: 30659164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal sodium butyrate supplement elevates the lipolysis in adipose tissue and leads to lipid accumulation in offspring liver of weaning-age rats.
    Zhou J; Gao S; Chen J; Zhao R; Yang X
    Lipids Health Dis; 2016 Jul; 15(1):119. PubMed ID: 27449927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs.
    Zhang X; Zhu B; Lin P; Liu X; Gao J; Yin D; Zeng J; Liao B; Kang Z
    Front Endocrinol (Lausanne); 2022; 13():1057905. PubMed ID: 36568082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.
    Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V
    Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice.
    Geisler CE; Hepler C; Higgins MR; Renquist BJ
    Nutr Metab (Lond); 2016; 13():62. PubMed ID: 27708682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future of GPR109A agonists in the treatment of dyslipidaemia.
    Wanders D; Judd RL
    Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.